文献速递消化内镜消化道肿瘤与早癌

稀释肾上腺素在胃内镜黏膜下剥离术中的应用:一项国际随机对照试验

The use of diluted epinephrine during gastric endoscopic submucosal dissection: an international randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2026-01-29

这项国际多中心随机对照试验纳入800例胃黏膜肿瘤行ESD患者,随机分为肾上腺素组(1:100,000稀释肾上腺素注射溶液)和对照组,主要终点为手术时间。

要点

  • 稀释肾上腺素加入黏膜下注射溶液可显著缩短胃ESD手术时间。
  • 肾上腺素组需止血钳的术中出血次数显著少于对照组。
  • 两组术后不良事件无显著差异。

核心结论

  • 在黏膜下注射溶液中加入稀释肾上腺素可显著缩短胃ESD的手术时间。

研究设计与样本

  • 国际多中心随机对照试验,在12家机构开展,纳入胃黏膜肿瘤行ESD患者,随机分为肾上腺素组(1:100,000稀释肾上腺素注射溶液)和对照组,按病变位置、大小和机构分层,患者、内镜医师和评估者盲法。
  • 共800例入组,774例纳入最终改良意向治疗分析,肾上腺素组386例,对照组388例。

主要发现

  • 两组术后不良事件无显著差异。

临床怎么用

  • 胃ESD中可在黏膜下注射溶液中加入1:100,000稀释肾上腺素以缩短手术时间并减少需止血钳的术中出血。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is the standard treatment for early gastric cancer. Intraprocedural bleeding during gastric ESD may result in prolonged procedure time. Therefore, we investigated the efficacy of adding diluted epinephrine to a submucosal injection solution to reduce the procedure time in gastric ESD. METHODS: This international, multicenter, randomized controlled trial was conducted across 12 institutions. Patients with gastric mucosal neoplasia who underwent ESD were eligible. The patients were randomly allocated to either the epinephrine group (1:100,000 diluted epinephrine-added injection solution) or the control group. Randomization was stratified according to lesion location, size, and institution. Patients, endoscopists, and assessors were blinded to the treatment allocation. The primary outcome was the procedure time. Secondary outcomes included the number of intraprocedural hemorrhages requiring the use of hemostatic forceps and postprocedural adverse events. RESULTS: A total of 800 patients were enrolled, 774 of whom were included in the final modified intention-to-treat analysis. A total of 386 and 388 patients were randomized into the epinephrine and control groups, respectively. The mean (SD) procedure time was significantly shorter in the epinephrine group than in the control group: 60 (46) versus 68 (45) minutes, respectively (P = .018). The number of intraprocedural hemorrhages requiring hemostatic forceps was significantly lower in the epinephrine group (mean count: 1.8 vs 3.0; P < .001). There were no significant differences in postprocedural adverse events between the groups. CONCLUSIONS: The addition of diluted epinephrine to the injection solution significantly reduces the procedure time for gastric ESD. (ClinicalTrials.gov: NCT04032119.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Yip HC, Uedo N, Iwagami H, et al. The use of diluted epinephrine during gastric endoscopic submucosal dissection: an international randomized controlled trial. Gastrointest Endosc. 2026. PMID: 41620139. doi:10.1016/j.gie.2026.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。